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Abstract
Background: Evaluating copy numbers of given genes in Plasmodium falciparum parasites is of
major importance for laboratory-based studies or epidemiological surveys. For instance, pfmdr1
gene amplification has been associated with resistance to quinine derivatives and several genes
involved in anti-oxidant defence may play an important role in resistance to antimalarial drugs,
although their potential involvement has been overlooked.
Methods: The ∆∆Ct method of relative quantification using real-time quantitative PCR with SYBR
Green I detection was adapted and optimized to estimate copy numbers of three genes previously
indicated as putative candidates of resistance to quinolines and artemisinin derivatives: pfmdr1,
pfatp6 (SERCA) and pftctp, and in six further genes involved in oxidative stress responses.
Results: Using carefully designed specific RT-qPCR oligonucleotides, the methods were optimized
for each gene and validated by the accurate measure of previously known number of copies of the
pfmdr1 gene in the laboratory reference strains P. falciparum 3D7 and Dd2. Subsequently, Standard
Operating Procedures (SOPs) were developed to the remaining genes under study and successfully
applied to DNA obtained from dried filter blood spots of field isolates of P. falciparum collected in
São Tomé & Principe, West Africa.
Conclusion: The SOPs reported here may be used as a high throughput tool to investigate the
role of these drug resistance gene candidates in laboratory studies or large scale epidemiological
surveys.
Background
In the absence of a viable vaccine, current methods used
for the control of malaria invariably rely on prevention
through minimizing exposure to mosquitoes, and drug
treatment of clinical disease. In areas of high transmis-
sion, where large numbers of malaria cases are presently
inevitable, there is a reliance on anti-malarial drugs to
treat the disease. However, parasite resistance, especially
of Plasmodium falciparum, has been recorded to every anti-
malarial drug currently in use [1].
It has been shown that differential copy numbers and/or
differential transcription of putative drug resistance gene
candidates may influence responses to drugs in malaria
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parasites. For instance, both in laboratory-adapted strains
and clinical samples of P. falciparum increased copy num-
bers of the pfmdr1 gene have been implicated in resistance
to quinine derivatives [2,3]. Additionally, changes in copy
numbers of other genes, such as those coding for antioxi-
dant defense enzymes, may be important in antimalarial
drug resistance although these have not been fully
explored as putative candidates [2,4]. In this context, is
has been shown that higher levels of glutathione (GSH) in
some parasites may help protect them from the toxic
effects of chloroquine and thus contribute to resistance.
Both in P. falciparum and in the rodent malaria parasite
Plasmodium berghei, CQ-resistant lines contained higher
levels of GSH than their sensitive counterparts [5], and
this was related to increased expression of glutathione-s-
transferase (gst) [6,7]. In addition, other anti-oxidant
stress genes such as thioredoxins, have been widely shown
to confer resistance to artesunate in tumor cells [8], but
these have scarcely investigated in the context of drug-
resistant malaria.
More recently, Uhlemann and colleagues provided strong
evidence to indicate that resistance to artemisinins may
depend on single nucleotide polymorphisms in the drug's
putative chemotherapeutic target, the SERCA-type ATPase
protein of P. falciparum (PfATP6) [9], although epidemio-
logical evaluation of gene copy numbers in natural para-
site populations has not been carried out.
Previous reports have described protocols for estimating
copy numbers of the pfmdr1, using real-time quantitative
PCR (RT-qPCR) [10,11]. Although the methods were
shown to be highly sensitive, the fluorescent PCR signal
was detected with TaqMan or hybridization probes spe-
cific for the mdr1 gene exclusively.
The objective of the present work was to develop proto-
cols to estimate candidate gene copy numbers in genomic
DNA extracted from dried blood spots of laboratory-
adapted strains and field-collected isolates of P. falci-
parum, using RT-qPCR with SYBR green I detection. The
genes included in the study were chosen on the basis of
either a previous involvement in antimalarial drug resist-
ance or their involvement in parasite responses to antioxi-
dant stress (Table 1). SYBR Green I fluorescent dye has the
important property of being a sequence-independent,
universal RT-qPCR detection system, due to its ability to
bind to all dsDNA molecules. Therefore, when working
with a large panel of genes, using SYBR green instead of
probes is another way to meet the demand of high
throughput and to work more cost effectively.
Although SYBR Green I detection is prone to lack of spe-
cificity, its comparative low price and ability to detect any
given PCR product in a sequence-independent manner
outweigh its potential disadvantages provided optimal
conditions are assured.
Methods
DNA extraction from laboratory clones and field isolates 
of P. falciparum
A set of eight DNA samples of P. falciparum from the Dem-
ocratic Republic of Sao Tomé & Principe (DRSTP) were
used in this study. Blood samples had been collected pre-
viously by Passive Case Detection (PCD) as part of an on-
going collaboration between Portugal and the DRSTP dur-
ing the month of February 2004, from suspected malaria
carriers attending the Centro Policlínico de Saúde de Água
Grande, in the city of São Tomé.
No age restrictions were applied. After confirmation of P.
falciparum infection by microscopical observation of thin
and thick Giemsa-stained blood films, 1 ml of venous
blood was collected into Monovettes containing EDTA,
after individual informed consent and local ethical
approval. A sub-sample of this was spotted onto What-
man n°4 filter paper and then parasite genomic DNA was
obtained from all samples by boiling in Chelex-100 [12]
followed by ethanol precipitation. A similar protocol was
used to extract genomic DNA from the references strains
Table 1: Genes analysed in this study
Gene annotation Abbreviation Chromosome Accession number
actin (housekeeping) β-actin1 12 NP_701803
multidrug resistance protein mdr1 5 NP_703574
calcium-transporting ATPase (SERCA) atp6 1 NP_703265
histamine-releasing factor, putative tctp 5 NP_703454
glutathione peroxidase gpx 12 NP_701484
glutathione reductase gr 14 NP_702080
glutathione S-transferase gst 14 NP_702075
fe-superoxide dismutase sod1 8 NP_704405
trx peroxidase (2-Cys peroxiredoxin) trx1 14 NP_702257
thioredoxin peroxidase trx2 12 NP_701510Malaria Journal 2006, 5:1 http://www.malariajournal.com/content/5/1/1
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P. falciparum 3D7 and Dd2, which were kept in deep fro-
zen stabilates and cultured in vitro at the time of these
experiments.
Oligonucleotide primer design
Using data deposited in P. falciparum GeneDB [13], P. fal-
ciparum  3D7 individual cDNA gene sequences were
retrieved and used as template for designing all real-time
PCR oligos (Table 2).
Real-time PCR oligonucleotide primers were manually
designed for each of the genes to assure maximal effi-
ciency and sensitivity, according to the following parame-
ters: avoidance of the formation of self and hetero-dimers,
hairpins and self-complementarity, primer length and
melting temperature. These properties were verified using
two different internet-based interfaces: Primer-3 [14] and
Oligonucleotide Properties Calculator [15]. When possi-
ble, "GC clamps" were placed at the 3'-end of each primer
to minimize breathing between primer and template
DNA, which can promote mispriming and decrease effi-
ciency. Primers were designed such that amplicon sizes
ranged between 50 and 250 bps. Melting curve analysis
was always performed at the end of each PCR assay to con-
trol for specificity; specific reactions should result in a sin-
gle melting peak corresponding to the PCR product being
amplified. In contrast, multiple melting peaks imply that
that the reaction is either unspecific in that it originates
more than one amplicon or that primer dimers are being
formed. Either condition alters the validity of PCR kinetic
parameters and, thus, any primer pairs producing more
than one melting peak were discarded.
Real-time PCR assays
Real-time PCR was performed in the GenAmp 5700 SDS®
(Applied Biosystems™), using the default thermocycler
program for all genes: 10 minutes of pre-incubation at
95°C followed by 40 cycles for 15 seconds at 95°C and
one minute at 60°C.
Individual real-time PCR reactions were carried out in 20
µl volumes in a 96-well plate (Applied Biosystems™) con-
taining 1× buffer (10×), 3.5 mM MgCl2, 200 µM dNTPs,
different concentrations of sense and antisense primers
(Table 2), 0.025 U/µl enzyme and 1:66000 SYBR GreenI
®. All reactions were made using qPCR™ Core Kit for SYBR
Green I® (EUROGENTEC™).
At the end of each reaction, Cycle threshold (Ct) was man-
ually setup at the level that reflected the best kinetic PCR
parameters, and melting curves were acquired and ana-
lysed.
Data analysis using the 2-∆∆Ct method and its validation
The two most commonly used methods to analyse data
from real-time, quantitative PCR experiments are absolute
quantification and relative quantification. Absolute quan-
tification is usually applied to determine the input copy
number, usually by relating the PCR signal to a standard
curve. Relative quantification is more commonly used to
measure gene expression by relating the PCR signal of the
target transcript in a treatment group to that of a sample
such as an untreated control. Absolute quantification is
usually more accurate but requires elaboration of stand-
ard curves for each gene under study that need be ran at
Table 2: Real-time quantitative PCR primers
Gene Primer Sequence (5' ⇒ 3') Concentration (nm) Amplicon size (bp)
Pf-β-actin1 sense GGA CAC ATA TTG TGC CTG C 300 90
antisense CTC CAC TAT CTA ACA CAA TAC C 300
Pf-mdr1 sense CAA GTG AGT TCA GGA ATT GGT AC 300 230
antisense GCC TCT TCT ATA ATG GAC ATG G 300
Pf-atp6 sense GCT GCA TTC ATT AGT TTC GTG 300 126
antisense GCC ATA CAC CTA CGG CAG C 600
Pf-tctp sense CAA ATG ATG AAG TAT GTT CCG 300 55
antisense GGT ACT TCA AAT GGA TCT TGT TG 600
Pf-gpx sense CGT CGA TAA AAA TGG AGA AGT TG 300 56
antisense CTA ACG GGT TTG TTT TGG GTG 600
Pf-gr sense GCA GTG GCC TTA AAA ATG AAT G 300 68
antisense GCT GTA GGA TGT ATA GGT ATG G 300
Pf-gst sense GAT GCA AGG GGT AAA GCT G 300 150
antisense GGG TAC TTG CTC AAA AGG AG 600
Pf-sod1 sense GAT TAC AGA AAT GAC AGA GCA TC 300 56
antisense CAA TTT ACT AGG TTC CAC CAA G 600
Pf-trx1 sense CAT ATG TAG GAA GAG AAG CTC C 300 53
antisense ATC TGC AAA AAC TGC TTC AGC C 600
Pf-trx2 sense CGC TAG TGA CAA AGA AGG C 300 60
antisense ACA AAC AAC AGT ATT TCT GAC C 600Malaria Journal 2006, 5:1 http://www.malariajournal.com/content/5/1/1
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each experiment, thus increasing experimental costs and
significantly decreasing throughput.
In this work, the 2-∆∆Ct method of relative quantification
(described in detail in [16]) was adapted to estimate copy
numbers in P. falciparum genes. This method allows to
estimate gene copy numbers in unknown samples, requir-
ing two main pre-requisites. The first is the existence of at
least one calibrator consisting of template DNA with
known copies of each of the studied genes. The second is
the need to have a house-keeping gene of constant copy
number in all samples, which permits normalization of
the quantitative data. In this work, genomic DNA
extracted from P. falciparum 3D7, known to harbour a sin-
gle copy of each gene studied, was used as calibrator,
while Pf-β-actin1 served as the house-keeping gene in all
experiments.
The ∆∆Ct calculation for the relative quantification of tar-
get was used as follows ∆∆Ct = (Ct, target gene – Ct, Pf-β-
actin1)χ – (Ct, target gene – Ct, Pf-β-actin1)y, where χ =
unknown sample and y = P. falciparum 3D7. After valida-
tion of the method, results for each sample were expressed
in N-fold changes in χ target gene copies, normalized to
Pf-β-actin-1 relative to the copy number of the target gene
in P. falciparum 3D7, according to the following equation:
amount of target = 2-∆∆Ct [16]. A minimum of two experi-
ments was carried out for each gene and sample. At each
experiment, each individual sample was run in triplicate
wells and the Ct of each well was recorded at the end of
the reaction. The average and standard deviation (SD) of
the three Cts was calculated and the average value was
accepted if the SD was lower than 0.38 [17]. Results for
each sample were expressed as the N-fold copy number of
a given gene relative to P. falciparum 3D7, by calculating
the geometric mean between the two experiments. Assays
were repeated if amplification curves did not reflect expo-
nential kinetic parameters or if the N-fold copy number of
a given gene was lower than 0.7 or higher than 1.3. In
cases where N-fold was comprehended between those val-
ues (0.7 <N-fold< 1.3), it was accepted that the test sample
harboured a single copy of the target gene, i.e., N-fold = 1.
Determination of real-time PCR efficiencies
For the ∆∆Ct calculation to be valid, two important
parameters must be considered beforehand. First, the effi-
ciency of a given PCR amplification must be close to
100%, and second, the relative efficiency must be opti-
Typical results of estimation of pfmdr1 copy number in P. fal- ciparum Dd2 relative to 3D7 Figure 2
Typical results of estimation of pfmdr1 copy number in P. fal-
ciparum Dd2 relative to 3D7.
Calculation of relative efficiency of the P. falciparum glutath- ione reductase gene (Pfgr) Figure 1
Calculation of relative efficiency of the P. falciparum 
glutathione reductase gene (Pfgr). The average Ct at 
each dilution was calculated for both Pf-β-actin1 and the glu-
tathione reductase gene, Pfgr, and Ct, Pfgr-Ct, P-β-actin1 was 
determined (a). Plots of the log DNA dilution versus ∆Ct 
were made (b) and a slope was calculated from this (c). The 
absolute value of this slope (m) was 0.0286 (< 0.1) (d), 
reflecting optimal relative efficiency.Malaria Journal 2006, 5:1 http://www.malariajournal.com/content/5/1/1
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mal, that is, the amplification efficiencies of the target and
reference genes must be approximately equal [16]. In
order to determine PCR efficiencies for each gene, P. falci-
parum 3D7 genomic DNA was diluted in serial 10-fold
ranges and the Ct value at each dilution was measured. A
curve was then constructed for each gene from which effi-
ciency was determined. Real-time PCR efficiencies (E)
were calculated from the given slopes, according to the
equation: E = 10(-1/slope) - 1 × 100 [10], where E = 100 cor-
responds to 100% efficiency [12]. PCR reactions where
the amplicon doubles at every cycle have an optimal effi-
ciency of 100% compared to reactions where no amplifi-
cation occurs and efficiency is 0%.
To measure relative efficiency, amplifications were per-
formed on the same diluted samples, using primers for
the reference (Pf-β-actin1) and the target genes. The aver-
age Ct was calculated for both reference and target genes
and the ∆Ct (Ct, target gene – Ct, Pf-β-actin1) was deter-
mined. Plots of the log DNA dilution versus ∆Ct were
made. If the absolute value of the slope was close to zero
(m < 0.1), the efficiencies of the target and reference genes
were similar, and thus the ∆∆Ct calculation could be
applied.
Results and discussion
Reaction efficiencies and validation of the assay
Predicted coding sequences obtained for each gene were
used to design internal oligonucleotide primers for appli-
cation in real-time PCR (Figure 2 and Table 3) as
described in Materials and Methods section. Using these
primers, real-time PCRs were first optimised for each gene
by varying both primer and PCR reagent concentrations,
in order to obtain optimal efficiencies (data not shown).
After a number of rounds of optimisation for each gene
individual PCR efficiencies (E) neared 100% in all cases
(data not shown). This was also the case for the relative
efficiencies between each target gene and Pf-β-actin1.
Therefore, there was no need for efficiency correction. Fig-
ure 1 depicts an example assay for the calculation of rela-
tive PCR efficiency.
To further test the validity of the assays, the copy number
of the Pfmdr1 gene was compared between the laboratory
clones P. falciparum 3D7 and P. falciparum Dd2. The
clone 3D7 harbours one copy of the gene while the multi-
drug-resistant resistant line, Dd2, a derivative of W2mef,
contains 4 copies. [3,18]. After ensuring optimal condi-
tions for the pfmdr1 assay, the N-fold copy number of
Dd2 in comparison to 3D7 was evaluated in twenty inde-
pendent experiments, as depicted in an example in Figure
2. We note that this system was not directly compared to
that reported in references 10 and 11 and in addition, that
it would have been more informative to further validate
the assay with other Pfmdr1 multicopy strains. Neverthe-
less, the present observations indicated that the assay was
robust enough to ensure validation (Table 3).
Testing the methods on genomic DNA of natural parasite 
populations
After optimization of protocols for all different genes the
assays were deployed on genomic DNA extracted from
confirmed P. falciparum infections obtained from eight
isolates of the Democratic Republic of São Tomé and
Princípe. Parasite densities were determined in Giemsa-
stained blood smears and recorded as the number of par-
asites/µl of blood, assuming an average leukocyte count of
8,000/µl (all smears were examined against 500 leuco-
cytes prior to be declared negative). Parasite densities in
these isolates ranged from 2,500 to 500,000 parasites/µl.
For measuring the copy number of each gene in each sam-
ple, two microlitres of undiluted genomic DNA were used
as template for RT-qPCR regardless of parasitaemia.
Although it was observed that lower parasite densities
caused small shifts of amplification curves to the right
(reflecting higher Ct values), that did not influence the
outcome of relative kinetic parameters, since data was
Table 4: Estimated gene copy numbers in eight P. falciparum field-isolates from the DRSTP
Parasite Copy number relative to P. falciparum 3D7
Pfmdr1 Pfatp6 pftctp pfgpx pfgr pfgst Pfsod1 Pftrx1 Pftrx2
D d 2 3 . 7 11111111
S. Tomé 
strains
111111111
Legend: Eight strains from the islands of São Tomé and Princípe were tested (coded ST060, ST073, ST045, ST013, ST065, ST058 and ST035). For 
simplification, results are expressed in a single row, since all parasites harboured one copy of the studied genes.
Table 3: Estimation of pfmdr1 copy number in P. falciparum Dd2 
relative to 3D7, resulting from the analysis of 20 independent 
experiments
Previously reported Observed in present work
Mean Min. Max. SD
4 3.7 3.2 4.5 0.68Malaria Journal 2006, 5:1 http://www.malariajournal.com/content/5/1/1
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normalized against the β-actin1 gene (data not shown).
These experiments showed, however, that there was no
amplification in any of the genes among all isolates ana-
lysed (Table 4).
Conclusion
Protocols were developed to estimate copy numbers of
nine putative drug resistance candidate genes in P. falci-
parum. These were initially validated by accurate measure
of previously known number of copies of the pfmdr1 gene
in the drug-sensitive strain P. falciparum 3D7 and the
multi-drug resistant Dd2. Subsequently, protocols were
developed for 8 other genes, which were successfully
applied to DNA obtained from field isolates of P. falci-
parum collected in the DRSTP. In these particular case,
however, all isolates harboured a single copy of the genes
studied (Table 4).
The methodology was shown to be sensitive and specific
allowing copy number estimations using template DNA
extracted with chelex resin from filter paper blood spots,
independent of sample parasitaemia. Since all Standard
Operating Procedure were designed to function under
similar PCR temperatures and reagent concentrations,
multiple genes may be analysed in a 96-well optical plate,
significantly increasing throughput. The method by-
passes the need of gene-specific probes since it relies on
SYBR Green I detection and can, thus, be adapted to any
given gene provided optimal experimental conditions are
assured. As long as primers are properly constructed, most
genes are easily and reliably detected with the less cum-
bersome and less expensive SYBR green I detection
method.
Since the methodology relies on relative quantification, it
by-passes the need to measure DNA concentration in any
given sample. Although a quantification of target genes in
genomic DNA is reported, these methods should be
equally useful to measure gene expression using cDNA as
template, since all primers are located in exons, although
it is advisable that PCR efficiencies are calculated and opti-
mized if required, prior to such experiments.
For all reasons cited above, these protocols may be a
highly useful tool for high throughput large scale epide-
miological assays or laboratory studies.
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